Answers are grounded in this paper and cite their sources.
Ocular diseases are a serious health concern worldwide and demand effective drug delivery systems for better treatment results. Traditional eye medicines such as drops and ointments are commonly used, but they often show poor effectiveness because the drug is quickly washed away by tears, drained through the tear ducts, and does not remain long on the eye surface. As a result, only a very small amount of the medicine, usually less than 5%, reaches the inside of the eye. To overcome these drawbacks, advanced drug delivery methods have been developed. Among them, ocular inserts have gained importance because they can provide controlled and long-lasting release of drugs. In recent years, three-dimensional (3D) printing, also called additive manufacturing, has emerged as a promising technique for making customized drug delivery devices. This technology allows accurate control over the shape, internal design, and drug distribution within the device. Therefore, 3D printing offers new opportunities to design patient-specific ocular inserts with improved treatment outcomes and predictable drug release. Different 3D printing methods have been studied for ophthalmic drug delivery, including fused deposition modeling, stereolithography, selective laser sintering, and inkjet printing. This review focuses on the use of 3D printing in the design and preparation of ocular inserts. It explains the barriers in the eye that limit drug delivery, the shortcomings of conventional eye medicines, the types of ocular inserts, and the role of various polymers in their formulation. It also highlights the different 3D printing techniques applied in pharmaceutical manufacturing, their applications in ophthalmic drug delivery, and recent progress in the development of 3D-printed ocular inserts. Finally, the review discusses the present challenges, regulatory aspects, and future directions for bringing 3D-printed ocular drug delivery systems into clinical practice.
No takes yet. Share an insight, caveat, or question.
Mangale et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: